成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Asunaprevir

別名: BMS-650032 中文名稱:阿那匹韋

Asunaprevir是具有口服活性的HCV NS3抑制劑。HCV NS3是病毒復制蛋白加工所必需的蛋白酶。

Asunaprevir Chemical Structure

Asunaprevir Chemical Structure

CAS: 630420-16-5

規(guī)格 價格 庫存 購買數(shù)量
10mM (1mL in DMSO) 2022.93 現(xiàn)貨
2mg 794.51 現(xiàn)貨
5mg 1777.89 現(xiàn)貨
25mg 5381.51 現(xiàn)貨
100mg 12858.96 現(xiàn)貨
1g 49713.79 現(xiàn)貨
更大包裝 有超大折扣

400-668-6834

info@selleck.cn

免費分裝
免費預溶

Asunaprevir相關(guān)產(chǎn)品

相關(guān)信號通路圖

細胞實驗數(shù)據(jù)示例

細胞系 實驗類型 給藥濃度 孵育時間 活性描述 文獻信息
Huh7.5 replicon cells Antiviral assay 4 days Antiviral activity against HCV genotype 1b infected in human Huh7.5 replicon cells assessed as reduction in viral replication incubated for 4 days by luciferase reporter gene assay, EC50=0.006μM 29650290
HuH7.5 cells Antiviral assay 4 days Antiviral activity against HCV genotype 1b Con1 infected in human HuH7.5 cells assessed as inhibition of viral replication after 4 days by luciferase reporter gene assay, EC50=0.006μM 29456803
HuH7 replicon cells Function assay 4 days Inhibition of HCV genotype 1a H77 NS3 protease infected in human HuH7 replicon cells assessed as reduction in viral replication after 4 days by luciferase reporter gene assay, EC50=0.004μM 29162454
HuH7 replicon cells Function assay 4 days Inhibition of HCV genotype 1b Con1 NS3 protease infected in human HuH7 replicon cells assessed as reduction in viral replication after 4 days by luciferase reporter gene assay, EC50=0.0012μM 29162454
HuH7 cells Antiviral assay 3 days Antiviral activity against HCV genotype 1b infected in human HuH7 cells co-treated with daclatasvir after 3 days by luciferase reporter assay 28430437
HuH7 cells Antiviral assay 3 days Antiviral activity against HCV genotype 1b infected in human HuH7 cells at >= 10 times antiviral EC50 after 3 days by luciferase reporter assay 28430437
genotype 2a replicon cells Function assay Inhibition of recombinant full length HCV genotype 3a S52 NS3 protease in genotype 2a replicon cells by luciferase reporter gene assay, EC50=1.1μM 27564532
genotype 2a replicon cells Function assay Inhibition of recombinant full length HCV genotype 2b HC-J8 NS3 protease in genotype 2a replicon cells by luciferase reporter gene assay, EC50=0.621μM 27564532
HCV replicon cells Antiviral assay Antiviral activity against HCV genotype 2a JHF-1 in HCV replicon cells assessed as reduction in viral RNA replication by luciferase reporter gene assay, EC50=0.217μM 27564532
HCV replicon cells Antiviral assay Antiviral activity against HCV genotype 1a H77 in HCV replicon cells assessed as reduction in viral RNA replication by luciferase reporter gene assay, EC50=0.004μM 27564532
Huh7.5 cells Antiviral assay Antiviral activity against HCV genotype 1b Con1 expressing NS3 protease infected in human Huh7.5 cells assessed as reduction in viral RNA replication by luciferase reporter gene assay, EC50=0.003μM 27564532
genotype 1b con1 replicon cells Function assay Inhibition of recombinant full length HCV genotype 4a ED43 NS3 protease in genotype 1b con1 replicon cells by luciferase reporter gene assay, EC50=0.0017μM 27564532
點擊查看更多細胞系數(shù)據(jù)

生物活性

產(chǎn)品描述 Asunaprevir是具有口服活性的HCV NS3抑制劑。HCV NS3是病毒復制蛋白加工所必需的蛋白酶。
靶點
1b (J4L6S) [1] 1a (H77) [1] 6a (HK-6A) [1] 4a (ED43) [1] 5a (SA13) [1] 點擊更多
0.3 nM 0.7 nM 0.9 nM 1.6 nM 1.7 nM
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03208322 Withdrawn
Hepatitis C
Bristol-Myers Squibb
November 30 2018 --
NCT03004625 Completed
Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital|Chang Gung Memorial Hospital|National Taiwan University Hospital|Taipei Veterans General Hospital Taiwan|China Medical University Hospital|National Cheng-Kung University Hospital
November 2016 Phase 3
NCT02865369 Unknown status
Chronic Hepatitis C
Sang Gyune Kim|Seoul National University Boramae Hospital|Severance Hospital|Inha University Hospital|Korea University|Gachon University Gil Medical Center|Hanyang University Seoul Hospital|Ewha Womans University Mokdong Hospital|Bristol-Myers Squibb|Soonchunhyang University Hospital
September 2016 --
NCT02580474 Completed
Hepatitis C
Myeong Jun Song|Bristol-Myers Squibb|Soonchunhyang University Hospital|Dankook University|Chungnam National University Hospital|Konyang University Hospital|Eulji University Hospital|Saint Vincent''s Hospital Korea|Konkuk University Hospital|Cheongju St. Mary''s Hospital Cheongju Korea|Severance Hospital|Korea University Guro Hospital|Eulji General Hospital|The Catholic University of Korea
February 2016 Phase 4
NCT02496078 Completed
Hepatitis C
Bristol-Myers Squibb
August 2015 Phase 3
NCT02309450 Withdrawn
Hepatitis C Virus Genotype 4 Infection
ANRS Emerging Infectious Diseases|Bristol-Myers Squibb
December 2014 Phase 2

化學信息&溶解度

分子量 748.29 分子式

C35H46ClN5O9S

CAS號 630420-16-5 SDF --
Smiles CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C
儲存條件(自收到貨起)

體外溶解度
批次:

DMSO : 100 mg/mL ( (133.63 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO)

Ethanol : 100 mg/mL (133.63 mM)

Water : Insoluble

摩爾濃度計算器

體內(nèi)溶解度
批次:

現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑

動物體內(nèi)配方計算器

實驗計算

摩爾濃度計算器

質(zhì)量 濃度 體積 分子量

動物體內(nèi)配方計算器(澄清溶液)

第一步:請輸入基本實驗信息(考慮到實驗過程中的損耗,建議多配一只動物的藥量)

mg/kg g μL

第二步:請輸入動物體內(nèi)配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)

% DMSO % % Tween 80 % ddH2O
%DMSO %

計算結(jié)果:

工作液濃度: mg/ml;

DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);

體內(nèi)配方配制方法:μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。

體內(nèi)配方配制方法:μL DMSO母液,加入μL Corn oil,混勻澄清。

注意:1. 首先保證母液是澄清的;
2.一定要按照順序依次將溶劑加入,進行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。

技術(shù)支持

在訂購、運輸、儲存和使用我們的產(chǎn)品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術(shù)支持郵箱tech@selleck.cn,直接聯(lián)系到我們。我們會在24小時內(nèi)盡快聯(lián)系您。

操作手冊

如果有其他問題,請給我們留言。

* 必填項

請輸入您的姓名
請輸入您的郵箱地址 請輸入一個有效的郵箱地址
請寫點東西給我們
Tags: buy Asunaprevir | Asunaprevir supplier | purchase Asunaprevir | Asunaprevir cost | Asunaprevir manufacturer | order Asunaprevir | Asunaprevir distributor
在線咨詢
聯(lián)系我們